Who owns Theravance Biopharma?
- Ticker: TBPH
- CUSIP Number: g8807b106
Tip: Access positions for across all investors
Analyze quarterly positions in Theravance Biopharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Theravance Biopharma stock
Who bought or sold Theravance Biopharma this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Weiss Asset Management LP[1 | 7.5M | $67M | 0% | Mar 2024 |
|
Madison Avenue Partners | 7.0M | $79M | 0% | Dec 2023 |
|
BlackRock | 4.2M | $38M | -8% | Mar 2024 |
|
Irenic Capital Management | 2.8M | $25M | 0% | Mar 2024 |
|
Vanguard Group | 2.7M | $24M | -23% | Mar 2024 |
|
Pictet Asset Management Holding SA | 2.0M | $18M | 100% | Mar 2024 |
|
Newtyn Management | 1.6M | $15M | -13% | Mar 2024 |
|
Oasis Management | 1.2M | $10M | 21% | Mar 2024 |
|
Park West Asset Management | 1.2M | $10M | 29% | Mar 2024 |
|
Geode Capital Management | 968k | $8.7M | -9% | Mar 2024 |
|
D. E. Shaw & Co | 782k | $7.0M | -8% | Mar 2024 |
|
Jacobs Levy Equity Management | 558k | $5.0M | 42% | Mar 2024 |
|
Bank of America Corporation | 521k | $4.7M | -7% | Mar 2024 |
|
Northern Trust | 489k | $4.4M | -12% | Mar 2024 |
|
Morgan Stanley | 419k | $3.8M | 66% | Mar 2024 |
|
Charles Schwab Investment Management | 311k | $2.8M | -1% | Mar 2024 |
|
Wellington Management Company | 287k | $3.2M | 68% | Dec 2023 |
|
Dimensional Fund Advisors | 239k | $2.1M | 79% | Mar 2024 |
|
Goldman Sachs Group | 223k | $2.0M | -22% | Mar 2024 |
|
SG Americas Securities | 210k | $1.9M | 6% | Mar 2024 |
|
Chescapmanager | 201k | $1.8M | -12% | Mar 2024 |
|
Tudor Investment Corporation | 178k | $1.6M | 1661% | Mar 2024 |
|
Marshall Wace | 162k | $1.5M | 100% | Mar 2024 |
|
Bank of New York Mellon | 162k | $1.5M | -17% | Mar 2024 |
|
Nuveen Asset Management | 160k | $1.4M | -3% | Mar 2024 |
|
Hrt Financial | 131k | $1.2M | 68% | Mar 2024 |
|
State of Wisconsin Investment Board | 120k | $1.1M | 164% | Mar 2024 |
|
Citadel Advisors | 120k | $1.1M | -23% | Mar 2024 |
|
Credit Suisse | 115k | $1.0M | 0% | Mar 2024 |
|
Ameriprise Financial | 112k | $1.0M | 100% | Mar 2024 |
|
Rhumbline Advisers | 92k | $827k | -5% | Mar 2024 |
|
ExodusPoint Capital Management | 81k | $724k | -31% | Mar 2024 |
|
Alliancebernstein | 78k | $874k | 0% | Dec 2023 |
|
Swiss National Bank | 74k | $662k | -12% | Mar 2024 |
|
PDT Partners | 66k | $596k | 105% | Mar 2024 |
|
Bank Of Montreal | 66k | $599k | 100% | Mar 2024 |
|
Ubs Global Asset Management Americas | 65k | $579k | 0% | Mar 2024 |
|
Petrus Trust Company | 62k | $556k | 100% | Mar 2024 |
|
Ensign Peak Advisors | 61k | $546k | -5% | Mar 2024 |
|
Millennium Management | 60k | $538k | -50% | Mar 2024 |
|
UBS Group | 59k | $530k | -17% | Mar 2024 |
|
Royce & Associates | 59k | $529k | 0% | Mar 2024 |
|
NJ State Employees Deferred Compensation Plan | 58k | $522k | 0% | Mar 2024 |
|
Mirae Asset Global Investments | 53k | $559k | 17% | Mar 2024 |
|
Legal & General Group | 52k | $470k | 4% | Mar 2024 |
|
American Century Companies | 52k | $463k | 43% | Mar 2024 |
|
T. Rowe Price Associates | 50k | $444k | 8% | Mar 2024 |
|
Martingale Asset Management | 49k | $547k | -38% | Dec 2023 |
|
Russell Investments | 45k | $405k | 56% | Mar 2024 |
|
Barclays | 45k | $404k | -45% | Mar 2024 |
|
Assenagon Asset Management | 40k | $360k | 100% | Mar 2024 |
|
California State Teachers Retirement System | 39k | $345k | -31% | Mar 2024 |
|
Kennedy Capital Management | 38k | $343k | 4% | Mar 2024 |
|
Virtus ETF Advisers | 35k | $310k | 17% | Mar 2024 |
|
Jane Street | 34k | $302k | -91% | Mar 2024 |
|
Bnp Paribas Arbitrage, Snc | 34k | $300k | 31% | Mar 2024 |
|
Balyasny Asset Management | 31k | $281k | 100% | Mar 2024 |
|
Jpmorgan Chase & Co | 31k | $277k | -30% | Mar 2024 |
|
MetLife Investment Advisors | 30k | $333k | -13% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 28k | $250k | 2% | Mar 2024 |
|
American International | 26k | $288k | -9% | Dec 2023 |
|
Citigroup | 26k | $230k | 74% | Mar 2024 |
|
Henderson Group | 25k | $223k | 0% | Mar 2024 |
|
Brevan Howard Capital Management | 25k | $221k | -3% | Mar 2024 |
|
Florida State Board of Administration | 23k | $246k | 28% | Mar 2024 |
|
New York State Common Retirement Fund | 19k | $169k | 0% | Mar 2024 |
|
Cantor Fitzgerald, L. P. | 18k | $162k | 0% | Mar 2024 |
|
Ing Investment Management | 18k | $161k | -32% | Mar 2024 |
|
Wells Fargo & Company | 18k | $160k | 8% | Mar 2024 |
|
Graham Capital Management | 16k | $147k | 100% | Mar 2024 |
|
Campbell & Co. Investment Adviser | 16k | $139k | 100% | Mar 2024 |
|
Yakira Capital Management | 15k | $136k | -11% | Mar 2024 |
|
Corton Capital | 15k | $134k | 22% | Mar 2024 |
|
Principal Financial Group | 15k | $132k | -10% | Mar 2024 |
|
Zurcher Kantonalbank | 13k | $118k | 41% | Mar 2024 |
|
Franklin Resources | 13k | $116k | 0% | Mar 2024 |
|
Sawtooth Asset Management | 13k | $141k | 100% | Dec 2023 |
|
ProShare Advisors | 12k | $110k | 13% | Mar 2024 |
|
Engineers Gate Manager | 12k | $107k | 100% | Mar 2024 |
|
Point72 Asia | 12k | $106k | 100% | Mar 2024 |
|
Public Employees' Retirement Association of Colorado | 11k | $97k | -74% | Mar 2024 |
|
Arizona State Retirement System | 10k | $92k | -13% | Mar 2024 |
|
Man Group | 10k | $91k | -71% | Mar 2024 |
|
Gerber | 10k | $90k | 0% | Mar 2024 |
|
China Universal Asset Management | 9.6k | $86k | 66% | Mar 2024 |
|
Summit Investment Advisors | 6.1k | $55k | 0% | Mar 2024 |
|
Cubist Systematic Strategies | 5.8k | $52k | 100% | Mar 2024 |
|
Metropolitan Life Insurance Company | 3.5k | $39k | 0% | Dec 2023 |
|
Royal Bank of Canada | 2.9k | $27k | -83% | Mar 2024 |
|
FMR | 2.2k | $20k | -86% | Mar 2024 |
|
Aquatic Capital Management | 1.9k | $17k | 100% | Mar 2024 |
|
Amalgamated Bank | 1.7k | $15k | -69% | Mar 2024 |
|
Steward Partners Investment Advisory | 1.5k | $14k | 100% | Mar 2024 |
|
Pnc Financial Services | 1.1k | $9.7k | 671% | Mar 2024 |
|
Newbridge Financial Services Group | 1.0k | $9.0k | 0% | Mar 2024 |
|
CWM | 936.00 | $8.0k | 3644% | Mar 2024 |
|
Quadrant Capital | 747.00 | $6.7k | 161% | Mar 2024 |
|
Signature | 586.00 | $5.3k | -17% | Mar 2024 |
|
Us Bancorp | 508.00 | $4.6k | -65% | Mar 2024 |
|
GAMMA Investing | 434.00 | $3.9k | 1042% | Mar 2024 |
|
Tower Research Capital | 398.00 | $3.6k | -92% | Mar 2024 |
|
Global Retirement Partners | 300.00 | $2.7k | 0% | Mar 2024 |
|
Whittier Trust | 289.00 | $2.6k | 0% | Mar 2024 |
|
Daiwa Securities Group | 215.00 | $2.0k | 0% | Mar 2024 |
|
Advisor Group Holdings | 138.00 | $1.2k | 0% | Mar 2024 |
|
NISA Investment Advisors | 122.00 | $1.1k | 205% | Mar 2024 |
|
Riggs Asset Managment | 117.00 | $1.1k | 100% | Mar 2024 |
|
Parallel Advisors | 108.00 | $968.997600 | -93% | Mar 2024 |
|
Huntington National Bank | 88.00 | $788.999200 | 100% | Mar 2024 |
|
Pacific Center for Financial Services | 57.00 | $640.999200 | 0% | Dec 2023 |
|
Covestor | 44.00 | $0 | 63% | Mar 2024 |
|
Farther Finance Advisors | 23.00 | $208.000500 | -15% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 13.00 | $116.000300 | 100% | Mar 2024 |
|
Who sold out of Theravance Biopharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Highbridge Capital Management | Dec 2023 | 166k | $1.9B |
Susquehanna International | Sep 2023 | 125k | $1.1M |
GSA Capital Partners | Dec 2023 | 77k | $866k |
Squarepoint Ops | Dec 2023 | 52k | $585k |
Occudo Quantitative Strategies | Dec 2023 | 50k | $557k |
Walleye Trading | Dec 2023 | 43k | $481k |
Two Sigma Investments | Dec 2023 | 39k | $438k |
Dark Forest Capital Management | Sep 2023 | 32k | $274k |
Y-Intercept | Sep 2023 | 16k | $139k |
Bleakley Financial Group | Dec 2023 | 13k | $141k |
Teacher Retirement System Of Texas | Dec 2023 | 10k | $114k |
Natixis | Sep 2023 | 2.0k | $17k |
Fortitude Family Office | Dec 2023 | 441.00 | $5.0k |
Lindbrook Capital | Dec 2023 | 280.00 | $3.1k |
Hanson McClain Advisors | Dec 2023 | 178.00 | $2.0k |
Massmutual Trust | Dec 2023 | 42.00 | $472.000200 |